TL;DR
This pilot study explores the potential of a novel functional near-infrared spectroscopy (fNIRS) device, NIRSIT, for the real-time, bedside detection of acute cerebral infarction, specifically middle cerebral artery (MCA) occlusions. The findings suggest that NIRSIT can accurately identify areas of hypoperfusion by measuring cerebral oxygen saturation, correlating well with established imaging techniques like CT and MRI.
What Problem Does This Paper Address?
Acute ischemic stroke, particularly those caused by blockages in the middle cerebral artery (MCA) or internal carotid artery (ICA), is a leading cause of death and disability. Prompt diagnosis and treatment are crucial for improving patient outcomes, as interventions like thrombolysis and thrombectomy are most effective when administered quickly. Current gold-standard imaging techniques, such as perfusion computed tomography (PCT) and perfusion-weighted magnetic resonance imaging (PWI), are highly effective but require patients to be moved to specialized rooms, introducing delays. This paper addresses the need for a rapid, non-invasive, and accessible method for assessing cerebral perfusion status at the point of care, such as in the emergency department (ED) or even pre-hospital settings, to facilitate earlier detection and intervention for stroke.
Methods
The researchers conducted a prospective, observational pilot study involving nine adult patients presenting to the emergency department with suspected MCA or ICA infarction within 12 hours of symptom onset. The core of their methodology involved the use of the NIRSIT device, a portable, wireless fNIRS system equipped with 204 channels. NIRSIT works by measuring the absorption of near-infrared light (700-1000 nm) by hemoglobin, specifically differentiating between oxygenated (HbO2) and deoxygenated (HbR) forms. This allows for the non-invasive, real-time assessment of regional oxygen saturation (rSO2) and cerebral perfusion.
The NIRSIT device was applied to the patients' foreheads for 3-10 minutes during their neurological examination and before they were transferred for advanced imaging. The NIRSIT data, presented as 3D brain maps showing color-coded oxygenation levels, were then visually compared to the perfusion delay identified in PCT (using mean transit time - MTT) and PWI (using time-to-peak - TTP) maps. The study focused on a qualitative comparison due to the small sample size.
Datasets
Not discussed in the paper. The study involved direct patient measurements rather than training on or evaluating against pre-existing datasets.
Key Insights and Ideas
- Bedside Real-Time Perfusion Assessment: The most significant insight is the demonstration that NIRSIT can provide immediate, visual feedback on cerebral perfusion status directly at the patient's bedside. This bypasses the need for immediate transfer to specialized imaging suites, potentially shaving critical minutes off the diagnostic timeline.
- Correlation with Established Modalities: The study highlights a strong visual correlation between areas of reduced oxygen saturation detected by NIRSIT and areas of hypoperfusion identified by PCT and PWI. This suggests NIRSIT is capturing a physiologically relevant signal related to stroke-induced ischemia.
- Asymmetric Oxygenation as a Key Indicator: For all MCA infarction cases, NIRSIT consistently detected asymmetric cerebral oxygen saturation between the two hemispheres. This asymmetry appears to be a crucial indicator of localized perfusion deficits.
- Non-Invasive and Radiation-Free: The inherent advantages of fNIRS—being non-invasive, non-ionizing, and relatively low-cost—make it an attractive alternative or adjunct to existing imaging techniques, especially for frequent monitoring or in resource-limited settings.
Key Results
- Detection in All Cases: NIRSIT successfully detected MCA infarctions in all nine enrolled patients.
- Asymmetric rSO2: All MCA infarction cases showed different cerebral oxygen saturation values between the bilateral lobes of the brain in fNIRS imaging.
- Matching with PCT/PWI: The observed differences in cerebral oxygen saturation from NIRSIT imaging consistently matched the hypoperfusion findings on PCT and PWI.
- Patient Demographics: The study included nine patients (6 male, 3 female) with a median age of 74 years. The most common symptoms were unilateral extremity weakness (77.8%), dysarthria (33.3%), and aphasia (11.1%). The median NIHSS score was 17.
Limitations and Future Work
The authors acknowledge several limitations:
- Small Sample Size: This was a pilot study with only nine patients, necessitating a larger clinical study for robust validation.
- Limited Coverage: NIRSIT sensors primarily cover the frontotemporal area, meaning it cannot assess lacunar infarcts in deep brain structures or posterior circulation issues.
- No Hemorrhage Assessment: The study did not investigate the device's ability to detect or differentiate cerebral hemorrhage.
- Visual Comparison Only: Due to the small sample size, statistical analysis was not performed; findings were based on visual comparisons.
- No Post-Treatment Assessment: NIRSIT was not applied after thrombolysis or thrombectomy, limiting the ability to assess changes during treatment.
Future work should focus on larger, multi-center studies, potentially incorporating statistical analysis. Expanding sensor coverage to include more brain regions and investigating its utility in pre-hospital settings and for monitoring treatment response are also promising directions.
Summary updated